Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer

Simple item page
dc.contributor.authorGodoy Sánchez, Alejandro Samuel
dc.date.accessioned2016-05-10T18:15:09Z
dc.date.available2016-05-10T18:15:09Z
dc.date.issued2013
dc.identifier.doi10.18632/oncotarget.1314
dc.identifier.issn1949-2553
dc.identifier.urihttps://doi.org/10.18632/oncotarget.1314
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/13634
dc.language.isoen
dc.nota.accesocontenido completo
dc.relation.isformatofOncotarget Vol. 4, No. 12, p. 2225-2236.
dc.revistaONCOTARGETes_ES
dc.rightsacceso abierto
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.otherCáncer de próstataes_ES
dc.subject.otherQuimioterapiaes_ES
dc.subject.otherÁcidos hidroxámicoses_ES
dc.titleCombinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate canceres_ES
dc.typeartículo
dc.volumenVol. 4
sipa.codpersvinculados1011486
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Combinatorial antitumor effect of HDACs and the PI3K-Akt-mTOR pathway inhibition in a Pten deficient model of prostate cancer (art).pdf
Size:
3.04 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas